DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Writing G.
for the Edaravone (MCI-186) ALS 19 study group. Safety and efficacy of edaravone in well-defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
Lancet Neurol 2017;
16: 505-512
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.